Risk of Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study



      In this study, we aimed to estimate recurrence risk after incident venous thromboembolism, stratified according to unprovoked, provoked, and cancer-related venous thromboembolism in a prospective cohort of inpatients and outpatients receiving routine care.


      We linked nationwide Danish health registries to identify all patients with incident venous thromboembolism from January 2000 through December 2015. Rates of recurrence were calculated and Cox regression was used to compute hazard ratios (HRs) with 95% confidence intervals (CIs) by incident venous thromboembolism type after adjusting for coexisting risk factors.


      The study included 73,993 patients with incident venous thromboembolism (54.1% females; mean age, 62.3 years). At 6-month follow-up, rates per 100 person-years were 6.80, 6.92, and 9.06 for provoked, unprovoked, and cancer-related venous thromboembolism, respectively. At 10-year follow-up, corresponding rates were 2.22, 2.84, and 3.70, respectively. Additionally, at 6-month follow-up, hazard rates of recurrence were comparable for patients with unprovoked venous thromboembolism 1.01 (95% CI, 0.92-1.11) and provoked. At 10-year follow-up, unprovoked venous thromboembolism (HR, 1.17; 95% CI, 1.12-1.23) and cancer-related venous thromboembolism (HR, 1.21; 95% CI, 1.12-1.32) were associated with higher risk of recurrence compared with that found in provoked venous thromboembolism.


      In this nationwide cohort, patients with cancer-related venous thromboembolism had the highest risk of recurrence. At 6-month follow-up, there were similar risks of recurrence for patients with unprovoked and provoked venous thromboembolism. At 10-year follow-up, recurrence risks were similar for patients with unprovoked venous thromboembolism and patients with cancer-related venous thromboembolism. High recurrence risks in all categories indicate that further research is needed to optimize duration of extended anticoagulation for these patients.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Raskob GE
        • Angchaisuksiri P
        • Blanco AN
        • et al.
        Thrombosis: a major contributor to global disease burden.
        Arterioscler Thromb Vasc Biol. 2014; 34: 2363-2371
        • Prandoni P
        • Noventa F
        • Ghirarduzzi A
        • et al.
        The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
        Haematologica. 2007; 92: 199-205
        • Weitz JI
        • Jaffer IH
        • Fredenburgh JC
        Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants.
        F1000Res . 2017; 6: 985
        • Ensor J
        • Riley RD
        • Moore D
        • Snell KIE
        • Bayliss S
        • Fitzmaurice D
        Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE.
        BMJ Open. 2016; 6e011190
        • Kahn SR
        • Lim W
        • Dunn AS
        • et al.
        Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
        Chest. 2012; 141: e195S-226
      1. Mazzolai L, Aboyans V, Ageno W, et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function [e-pub ahead of print]. Eur Heart J. doi:10.1093/eurheartj/ehx003, Accessed July 7, 2018.

        • Schmidt M
        • Pedersen L
        • Sørensen HT
        The Danish Civil Registration System as a tool in epidemiology.
        Eur J Epidemiol. 2014; 29: 541-549
        • Lynge E
        • Sandegaard JL
        • Rebolj M
        The Danish National Patient Register.
        Scand J Public Health. 2011; 39: 30-33
        • Kildemoes HW
        • Sørensen HT
        • Hallas J
        The Danish National Prescription Registry.
        Scand J Public Health. 2011; 39: 38-41
        • Severinsen MT
        • Kristensen SR
        • Overvad K
        • Dethlefsen C
        • Tjønneland A
        • Johnsen SP
        Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution.
        J Clin Epidemiol. 2010; 63: 223-228
        • Riva N
        • Ageno W
        Approach to thrombosis at unusual sites: splanchnic and cerebral vein thrombosis.
        Vasc Med. 2017; 22: 529-540
        • Kearon C
        • Akl EA
        • Ornelas J
        • et al.
        Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report.
        Chest. 2016; 149: 315-352
        • Konstantinides S V.
        • Torbicki A
        • Agnelli G
        • et al.
        2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.
        Eur Heart J. 2014; 35: 3033-3080
        • Kearon C
        • Ageno W
        • Cannegieter SC
        • Cosmi B
        • Geersing GJ
        • Kyrle PA
        Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH.
        J Thromb Haemost. 2016; 14: 1480-1483
        • Goldhaber SZ
        Risk factors for venous thromboembolism.
        J Am Coll Cardiol. 2010; 56: 1-7
        • Goldhaber SZ
        • Tapson VF
        A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis.
        Am J Cardiol. 2004; 93: 259-262
        • Sundbøll J
        • Adelborg K
        • Munch T
        • et al.
        Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study.
        BMJ Open. 2016; 6e012832
        • Wallace R
        • Anderson M-A
        • See K
        • Gorelik A
        • Irving L
        • Manser R
        Venous thromboembolism management practices and knowledge of guidelines: a survey of Australian haematologists and respiratory physicians.
        Intern Med J. 2017; 47: 436-446
        • Wang I
        • Davenport MS
        • Kazerooni EA
        Imaging trends in acute venous thromboembolic disease: 2000 to 2015.
        J Am Coll Radiol. 2017; 14: 1151-1160
        • Austin PC
        • Lee DS
        • Fine JP
        Introduction to the analysis of survival data in the presence of competing risks.
        Circulation. 2016; 133: 601-609
        • Martinez C
        • Cohen AT
        • Bamber L
        • Rietbrock S
        Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer.
        Thromb Haemost. 2014; 112: 255-263
        • Arshad N
        • Bjøri E
        • Hindberg K
        • Isaksen T
        • Hansen J-B
        • Braekkan SK
        Recurrence and mortality after first venous thromboembolism in a large population-based cohort.
        J Thromb Haemost. 2016; 38: 42-49
        • Chua CC
        • Lim HY
        • Tacey M
        • Nandurkar H
        • Ho P
        Retrospective evaluation of venous thromboembolism: are all transient provoking events the same?.
        Eur J Haematol. 2017; 99: 18-26
        • Kniffin WD
        • Baron JA
        • Barrett J
        • Birkmeyer JD
        • Anderson FA
        The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly.
        Arch Intern Med. 1994; 154: 861-866
        • Schulman S
        • Rhedin A-S
        • Lindmarker P
        • et al.
        A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism.
        N Engl J Med. 1995; 332: 1661-1665
        • Baglin T
        • Luddington R
        • Brown K
        • Baglin C
        Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study.
        Lancet. 2003; 362: 523-526
        • Carrier M
        • Le Gal G
        • Wells PS
        • Rodger MA
        Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.
        Ann Intern Med. 2010; 152: 578-589